FDA Grants New Clearance for NICO Corporation's Brain Surgery Technology Post author:Sam Post published:January 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Biogen and AbbVie Voluntarily Pull Multiple Sclerosis Drug Off the Market March 1, 2018 This Drug Could be Johnson & Johnson's Next Billion-Dollar Blockbuster January 25, 2017 Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017
Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017